| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.003 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.004 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |